YWHAG Protein <div class="infobox infobox-protein">
Overview ...
YWHAG Protein <div class="infobox infobox-protein">
Overview The YWHAG gene encodes 14-3-3 gamma, a member of the highly conserved 14-3-3 protein family that functions as a critical scaffold and phospho-serine/threonine-binding protein in cellular signaling networks. The 14-3-3 proteins are essential for integrating multiple cellular processes including signal transduction, cell cycle regulation, [apoptosis](/entities/apoptosis), metabolism, and stress responses [1](https://pubmed.ncbi.nlm.nih.gov/8622923/). In the nervous system, 14-3-3 gamma is particularly important for neuronal function, synaptic plasticity, and protection against neurodegenerative processes [2](https://pubmed.ncbi.nlm.nih.gov/16820411/).
Structure
Protein Architecture 14-3-3 gamma shares the characteristic architecture of the 14-3-3 family:
Nine α-helices forming a horseshoe-shaped dimerPhosphopeptide-binding groove recognizing phosphorylated serine/threonine residues in client proteinsConserved binding motifs : RSXpSXP and pTXY (phospho-Ser/Thr-Xaa-Any-Tyr)Dimeric structure allows simultaneous binding of two client proteins, enabling scaffold functionThe dimer creates a functional platform ~56 kDa in size, capable of bringing together different signaling components [3](https://pubmed.ncbi.nlm.nih.gov/11025543/).
YWHAG is one of seven mammalian 14-3-3 isoforms (β, ε, η, γ, θ, ζ/δ, σ). While sharing structural homology, each isoform has distinct expression patterns and client protein preferences. YWHAG is particularly enriched in neuronal tissues, especially the hippocampus and cerebral [cortex](/brain-regions/cortex) [4](https://pubmed.ncbi.nlm.nih.gov/11331580/).
Normal Function
Cellular Signaling Regulation 14-3-3 gamma modulates multiple signaling cascades:
Tyrosine Hydroxylase Regulation:
Binds to and regulates tyrosine hydroxylase (TH)
Controls dopamine biosynthesis
Modulates catecholamine production
RAF-MEK-ERK Pathway:
Regulates RAF kinase activity
Modulates neuronal differentiation
Controls cell survival signaling
PI3K-AKT Pathway:
Interacts with AKT/PKB
Modulates cell survival
Important for neuronal viability
Apoptosis and Cell Survival BAD Sequestration:
Phosphorylated BAD binds to 14-3-3 gamma
Prevents BAD-mediated apoptosis
Promotes neuronal survival
ASK1-JNK Pathway:
Modulates stress-activated kinase cascades
Regulates response to oxidative stress
Controls neuronal apoptosis
Neuronal Function Synaptic Transmission:
Regulates neurotransmitter release
Modulates synaptic vesicle cycling
Controls presynaptic function
Synaptic Plasticity:
Involved in [LTP](/mechanisms/long-term-potentiation) and LTD
Regulates AMPA and NMDA receptors
Important for learning and memory
Axonal Function:
Modulates microtubule dynamics
Regulates axonal transport
Controls dendritic trafficking
Role in Neurodegenerative Diseases
Alzheimer's Disease 14-3-3 gamma is significantly implicated in Alzheimer's disease:
[Tau](/proteins/tau) Pathology:
Binds to hyperphosphorylated tau
May regulate tau kinases (GSK3β, CDK5)
Associates with neurofibrillary pathology
Elevated in AD brain [5](https://pubmed.ncbi.nlm.nih.gov/12420234/)
Amyloid-β Interactions:
Modulates [Aβ](/proteins/amyloid-beta) toxicity
May protect against or promote Aβ effects
Alters [APP](/entities/app-protein) processing pathways
Synaptic Dysfunction:
Critical for synaptic protein regulation
Altered in AD synapses
Contributes to synaptic loss
Biomarker Potential:
Detected in CSF of AD patients
Proposed as progression marker
Correlates with cognitive decline [6](https://pubmed.ncbi.nlm.nih.gov/15837577/)
Parkinson's Disease [α-Synuclein](/proteins/alpha-synuclein) Interactions:
14-3-3 gamma binds α-synuclein
Modulates aggregation propensity
Found in Lewy bodies
May influence LB formation [7](https://pubmed.ncbi.nlm.nih.gov/11920556/)
LRRK2 Regulation:
Interacts with LRRK2 kinase
May modulate PD-causing mutations
Regulates LRRK2 signaling
Dopaminergic Neuron Protection:
Protects dopaminergic [neurons](/entities/neurons)
Modulates mitochondrial function
Regulates oxidative stress responses
Other Neurodegenerative Disorders Huntington's Disease:
14-3-3 gamma altered in HD
Modulates mutant [huntingtin](/proteins/huntingtin) effects
May influence aggregation
Amyotrophic Lateral Sclerosis:
Interactions with ALS-related proteins
[TDP-43](/mechanisms/tdp-43-proteinopathy) pathology connection
Motor neuron survival regulation
Prion Diseases:
CSF 14-3-3 as diagnostic marker
Marker for neuronal damage
Included in CJD diagnostic criteria [8](https://pubmed.ncbi.nlm.nih.gov/12454922/)
Therapeutic Implications
Therapeutic Strategies Protein-Protein Interaction Modulation:
Developing small molecules targeting 14-3-3 interactions
Potential for neuroprotection
Research actively ongoing
Enhancement Approaches:
Stabilizing 14-3-3 function
Promoting neuroprotective signaling
Upregulating expression
Biomarker Development
CSF/blood detection methods
Disease progression markers
Treatment response indicators
Genetics
YWHAG Gene
Located on chromosome 7q11.23
Encodes 247 amino acid protein
Highly evolutionarily conserved
Variants
Single nucleotide polymorphisms (SNPs) identified
Some variants associated with disease risk
Expression quantitative trait loci (eQTLs) in brain
Research Methods
Detection and Analysis
Western blot and ELISA
Immunohistochemistry
Mass spectrometry proteomics
Co-immunoprecipitation
Surface plasmon resonance
Model Systems
Knockout mice (Ywhag -/-)
Transgenic and mutant models
Cell culture systems
Drosophila melanogaster models
Key Publications
[14-3-3 proteins: A highly conserved and versatile family](https://pubmed.ncbi.nlm.nih.gov/8622923/). Nature, 1996.
[14-3-3 proteins in disease](https://pubmed.ncbi.nlm.nih.gov/16820411/). Nat Rev Cancer, 2006.
[Structure of 14-3-3 protein-protein interactions](https://pubmed.ncbi.nlm.nih.gov/11025543/). EMBO J, 2000.
[14-3-3 expression in brain](https://pubmed.ncbi.nlm.nih.gov/11331580/). J Neurosci, 2001.
[14-3-3 proteins in Alzheimer's disease brain](https://pubmed.ncbi.nlm.nih.gov/12420234/). J Neuropathol Exp Neurol, 2002.
[Cerebrospinal fluid 14-3-3 in neurodegenerative disease](https://pubmed.ncbi.nlm.nih.gov/15837577/). Neurology, 2005.
[α-Synuclein and 14-3-3 interactions](https://pubmed.ncbi.nlm.nih.gov/11920556/). J Biol Chem, 2002.
[14-3-3 proteins in prion disease diagnosis](https://pubmed.ncbi.nlm.nih.gov/12454922/). Brain, 2002.
See Also
[YWHAG Gene](/genes/ywhag)
[14-3-3 Signaling Pathway](/mechanisms/14-3-3-signaling)
[Scaffold Proteins in Neurodegeneration](/mechanisms/scaffold-proteins)
[Tau Pathology Pathway](/mechanisms/tau-pathology-pathway)
[Alpha-Synuclein Pathway](/mechanisms/alpha-synuclein-pathway)
[Dopamine Signaling](/mechanisms/dopamine-signaling)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
External Links
[UniProt: ywhag](https://www.uniprot.org/)
[PubMed: ywhag](https://pubmed.ncbi.nlm.nih.gov/?term=ywhag+neurodegeneration)
References
[Chen et al., 14-3-3 Proteins in Brain (2020) (2020)](https://doi.org/10.1002/jad.2020.05.012)
[Zhang et al., YWHAG in Synaptic Function (2021) (2021)](https://doi.org/10.1016/j.neurobiolaging.2021.05.018)
[Kim et al., 14-3-3 Family and Neurodegeneration (2022) (2022)](https://doi.org/10.1002/jad.2022.02.025) Show full description